[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Kymera Therapeutics Inc (KYMR)

Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Kymera Therapeutics Inc 500 North Beacon Street 4th Floor Watertown MA 02472 USA

www.kymeratx.com Employees: 238 P: 857-285-5300

Sector:

Medical

Description:

Kymera Therapeutics Inc. is a biopharmaceutical company. It is focused on discovering and developing small molecule therapeutics for degrade dysregulated, disease-causing proteins to address previously intractable disease targets. Kymera Therapeutics Inc. is based in Watertown, United States.

Key Statistics

Overview:

Market Capitalization, $K 6,917,898
Enterprise Value, $K 6,560,888
Shares Outstanding, K 82,258
Float, K 69,113
% Float 84.02%
Short Interest, K 9,622
Short Float 11.70%
Days to Cover 19.48
Short Volume Ratio 0.45
% of Insider Shareholders 15.98%

Financials:

Annual Sales, $ 39,210 K
Annual Net Income, $ -311,350 K
Last Quarter Sales, $ 34,370 K
Last Quarter Net Income, $ -69,230 K
EBIT, $ -359,130 K
EBITDA, $ -359,700 K

Growth:

1-Year Return 159.71%
3-Year Return 183.64%
5-Year Return 87.97%
5-Year Revenue Growth 15.22%
5-Year Earnings Growth -15.56%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.71 on 04/30/26
Next Earnings Date 08/10/26
Earnings Per Share ttm -3.53
EPS Growth vs. Prev Qtr 26.80%
EPS Growth vs. Prev Year 13.41%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

KYMR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -24.71%
Return-on-Assets % -22.05%
Profit Margin % -794.06%
Debt/Equity 0.00
Price/Sales 180.58
Price/Cash Flow N/A
Price/Book 4.60
Book Value/Share 18.72
Interest Coverage -840.49
60-Month Beta 2.06
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.